Dr. Perry Jansen, the health district’s medical director, gave the only presentation in favor of continuing to offer the COVID-19 vaccine. The health district serves more than 300,000 people in Canyon ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

The CDC recommends expanding pneumococcal vaccine eligibility to adults aged 50 and above, impacting disease prevention with Pfizer and Merck's vaccines.

U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

By Ava Gonzalez/UW News Lab Despite the current low totals of COVID-19 and flu cases, health officials are warning against complacency as Seattle approaches peak respiratory virus season and a 7 ...

An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's ...

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into ...